Mankind Pharma transfers OTC biz to subsidiary
Slump sale to be effective on or before October 1, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Business Strategies
El Toro Finserve LLP releases 2024 – Healthcare Investment Manifesto for India
Report builds on consumer sentiments and emerging trends to bet on the ideas that will become mainstream or even a unicorn by 2029
GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million…
We are continuing to lead the transformation of the analytical lab
Dr Samir Vyas, Country General Manager, Agilent India speaks on Agilent’s focus areas and growth plans, lessons from the pandemic,…
ISoP launches South Asian Chapter
The initiative will provide a great boost to PV and drug safety not only in India, but the four other South Asian countries namely…
A Superstar marriage?
Chandru Chawla, a pharma veteran, opines that Biocon and SII coming together is a milestone event in the evolution of Indian…
ISPE publishes ISPE APQ Guide: Management Responsibilities and Management Review
This is the second publication in the APQ Guide series that seeks to improve the state of pharmaceutical quality and ensure…
We might need to redefine our approach to drug discovery and approval to be prepared for the future
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his…
GenNext at SIRO Clinpharm
SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
HEAL Health Connect Solutions to host e-Summit on Emerging Dimensions in Pharma Excellence
Held in collaboration with Express Pharma, the virtual event will be held on August 20, followed by Pharma Excellence Awards
Our digital-funding-network will support India pharma’s next phase of super-growth
Ravi Tanniru, SVP Enterprise Sales, C2FO India explains C2FO’s concept to Viveka Roychowdhury, and why a high growth industry like…
Post-COVID, there will be a mix of various working models
Koki Sato, Country Head and GM, Takeda India talks about the company’s recent drug launch in India, its plans for the Indian…
How the AMR Action Fund intends to support antibiotic-focused biotechs
While focus is on the global deaths from COVID-19 crossing the six lakh mark, we have lost seven lakh people to antimicrobial…
Golden moment for India in key sectors including pharma over next 10 years: Venture capitalist
Indian ministers, key bureaucrats and technology industry leaders should put together a roadmap, set of regulations and…
FDI in pharma and related implications of COVID-19
Arvind Sharma, Partner - M&A and General Corporate, Shardul Amarchand Mangaldas & Co states that the pharma sector is well…
The new norm will be supply chain stress tests to build resilience
The COVID-19 crisis has thrown up unprecedented challenges and opportunities for the Indian pharma sector. Dr Arun Singh, Chief…